Relative Oral Bioavailability of GABA From Tomatoes
Plasmakinetics of GABA From Tomatoes as Compared to GABA From a Supplement, After a Single Oral Administration in Healthy Young Men
1 other identifier
interventional
12
1 country
1
Brief Summary
In this four-way crossover study, a plasmakinetic profile of GABA from tomatoes as compared to a gamma-aminobutyric acid (GABA) supplement in healthy young men will be established. In addition, a plasmakinetic profiles of glutamate from a supplement and from tomatoes as well as the effects of glutamate from tomatoes and a supplement on the GABA plasma levels will be determined. This study will therefore provide information about the effect of a food matrix on GABA plasmakinetics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2019
CompletedFirst Posted
Study publicly available on registry
September 11, 2019
CompletedStudy Start
First participant enrolled
November 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2019
CompletedJanuary 21, 2020
January 1, 2020
1 month
June 18, 2019
January 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Area under the plasma concentration versus time curve (AUC ) of plasma-time curves of GABA
After intake of a GABA supplement and tomatoes.
6 months
Peak Plasma Concentration (Cmax) of plasma-time curves of GABA
After intake of a GABA supplement and tomatoes.
6 months
Time to Peak Plasma Concentration (Tmax) of plasma-time curves of GABA
After intake of a GABA supplement and tomatoes.
6 months
Half-life (T1/2) of plasma-time curves of GABA
After intake of a GABA supplement and tomatoes.
6 months
Secondary Outcomes (8)
Area under the plasma concentration versus time curve (AUC) of plasma-time curves of glutamate
6 months
Peak Plasma Concentration (Cmax) of plasma-time curves of glutamate
6 months
Time to Peak Plasma Concentration (Tmax) of plasma-time curves of glutamate
6 months
Half-life (T1/2) of plasma-time curves of glutamate
6 months
Area under the plasma concentration versus time curve (AUC) AUC of plasma-time curves of GABA in response to a glutamate supplement.
6 months
- +3 more secondary outcomes
Study Arms (4)
Tomato
EXPERIMENTALSingle oral administration
GABA supplement
EXPERIMENTALSingle oral administration
Glutamate supplement
EXPERIMENTALSingle oral administration
Placebo
NO INTERVENTIONSingle oral administration, same volume of water that is distributed in the other arms
Interventions
1 gram of GABA dissolved in water.
A maximum of 8 grams glutamate, adjusted to amount of glutamate given in the tomato arm. Dissolved in water.
Eligibility Criteria
You may qualify if:
- BMI between 18.5 and 25 kg/m2
- Age is between 18 and 28 years
- Good general health
- Male
- Veins suitable for blood sampling
- Able to speak Dutch
You may not qualify if:
- Is currently suffering from a disease including mental disorders
- Has had any gastrointestinal condition/disease within the 3 months prior to the intervention
- Haemoglobin (Hb) level \< 8.5 mmol/L
- Has used medication in the two months before and/or during the intervention. Occasional use of NSAIDs or paracetamol (\<once a week on average) are is allowed.
- Reported weight loss or weight gain of \> 2 kg in the month prior to the intervention
- Use of dietary supplements, 3 weeks before-, or during the intervention.
- Allergic to products that are provided as part of the standardised diet
- Unwilling to consume the products that are part of the standardised diet
- Allergic to tomatoes
- (History of) drug abuse, in this case meaning \>1 x per month use of recreational drugs
- Smoking
- Alcohol consumption of \>10 standardised glasses per week.
- Not able to refrain from alcohol consumption 2 days before each test day
- Recent or planned blood donation (\<3 month prior to first study day or during intervention)
- Personnel of Wageningen University, department of Human Nutrition and Health,
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wageningen Universitylead
- Nunhemscollaborator
- Agrico Researchcollaborator
- Avebecollaborator
Study Sites (1)
Wageningen University, Division of Human Nutrition
Wageningen, Netherlands
Related Publications (1)
de Bie TH, Balvers MGJ, de Vos RCH, Witkamp RF, Jongsma MA. The influence of a tomato food matrix on the bioavailability and plasma kinetics of oral gamma-aminobutyric acid (GABA) and its precursor glutamate in healthy men. Food Funct. 2022 Aug 15;13(16):8399-8410. doi: 10.1039/d2fo01358d.
PMID: 35852458DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Renger Witkamp, PhD
Wageningen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2019
First Posted
September 11, 2019
Study Start
November 4, 2019
Primary Completion
December 5, 2019
Study Completion
December 5, 2019
Last Updated
January 21, 2020
Record last verified: 2020-01